Wednesday, June 10, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 101 of 200 Β· By data quality, then INN

  1. safinamide

    ARX-SAFINAMIDE Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    N04B
  2. safinamide mesylate

    SAFINAMIDE MESYLATE

    ORAL FDA: approved

  3. samarium sm-153 lexidronam pentasodium

    QUADRAMET

    INJECTION FDA: approved

  4. saquinavir

    FORTOVASE

    ORAL FDA: approved Β· EMA: withdrawn

    J05AE01
  5. saquinavir mesylate

    INVIRASE

    ORAL FDA: approved

  6. saralasin acetate

    SARENIN

    INJECTION FDA: approved

  7. sarilumab

    KEVZARA

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    L04AC14
  8. satralizumab

    ENSPRYNG

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AC
  9. sebelipase alfa

    KANUMA

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    A16
  10. secobarbital sodium

    SECONAL SODIUM

    RECTAL FDA: approved

  11. secretin

    SECRETIN-FERRING

    INJECTION FDA: approved

  12. secretin synthetic human

    CHIRHOSTIM

    INTRAVENOUS FDA: approved

  13. secretin synthetic porcine

    SECREFLO

    INTRAVENOUS FDA: approved

  14. secukinumab

    COSENTYX Novartis Pharmaceuticals

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AC10
  15. seladelpar lysine

    LIVDELZI

    ORAL FDA: approved

  16. selegiline

    ELDEPRYL Orion Laboratories Pty.

    TRANSDERMAL FDA: approved Β· TGA: approved

  17. selegiline hydrochloride

    ZELAPAR

    ORAL FDA: approved

  18. selenium sulfide

    SELSUN Sanofi-aventis Healthcare Pty Ltd

    TOPICAL FDA: approved Β· TGA: approved

  19. selenomethionine se-75

    SELENOMETHIONINE SE 75

    INJECTION FDA: approved

  20. selexipag

    UPTRAVI Janssen-Cilag Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    B01AC27
  21. selpercatinib

    RETEVMO

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EX22
  22. selumetinib

    KOSELUGO Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

  23. selumetinib sulfate

    KOSELUGO

    ORAL FDA: approved

  24. semaglutide

    OZEMPIC NovoThirteen

    SOLUTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    A10BJ06

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.